Key result
Amino acid changes in human norovirus GII.4 epitope D allow the virus to escape antibody binding without ablating cellular ligand binding.
Flexibility in epitope D of GII.4 norovirus strains allows escape from antibody-mediated herd immunity while maintaining cellular ligand binding and infectivity.
Answers are grounded in this paper and cite their sources.
May drive GII.4 variant emergence; animal data leaves open human vaccine and surveillance implications.
Human norovirus causes ∼20% of all acute gastroenteritis and ∼200,000 deaths per year, primarily in young children. Most epidemic and all pandemic waves of disease over the past 30 years have been caused by type GII.4 human norovirus strains. The capsid sequence of GII.4 strains is changing over time, resulting in viruses with altered ligand and antibody binding characteristics. The carbohydrate binding pocket of these strains does not vary over time. Here, utilizing unique viral sequences, we study how residues in GII.4 epitope D balance the dual roles of variable antibody binding site and cellular ligand binding stabilization domain, demonstrating that amino acid changes in epitope D can result in loss of antibody binding without ablating ligand binding. This flexibility in epitope D likely contributes to GII.4 strain persistence by both allowing escape from antibody-mediated herd immunity and maintenance of cellular ligand binding and infectivity.
No takes yet. Share an insight, caveat, or question.
Lindesmith et al. (2018) studied Human norovirus infection. Amino acid changes in GII.4 epitope D was evaluated on Antibody binding and cellular ligand binding. Amino acid changes in human norovirus GII.4 epitope D allow the virus to escape antibody binding without ablating cellular ligand binding.
Synapse has enriched 10 related papers. Consider them for comparative context: